{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:14:37Z","timestamp":1763572477210,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:00:00Z","timestamp":1553040000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CORPG3G0971","CORPG3G1001"],"award-info":[{"award-number":["CORPG3G0971","CORPG3G1001"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5453-3","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T07:04:14Z","timestamp":1553065454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3570-8565","authenticated-orcid":false,"given":"Ming-Wei","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-De","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Lang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Nan","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ta-Sen","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-Long","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Yuan","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chau-Ting","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,20]]},"reference":[{"issue":"5","key":"5453_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386. https:\/\/doi.org\/10.1002\/ijc.29210 .","journal-title":"Int J Cancer"},{"issue":"3","key":"5453_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ajpath.2013.10.028","volume":"184","author":"ES Knudsen","year":"2014","unstructured":"Knudsen ES, Gopal P, Singal AG. The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapy. Am J Pathol. 2014;184(3):574\u201383. https:\/\/doi.org\/10.1016\/j.ajpath.2013.10.028 .","journal-title":"Am J Pathol"},{"issue":"6","key":"5453_CR3","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264\u20131273.e1261. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.061 .","journal-title":"Gastroenterology"},{"issue":"2","key":"5453_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cld.2011.03.006","volume":"15","author":"KA McGlynn","year":"2011","unstructured":"McGlynn KA, London WT. The global epidemiology of hepatocellular carcinoma, present and future. Clin Liver Dis. 2011;15(2):223\u201343. https:\/\/doi.org\/10.1016\/j.cld.2011.03.006 .","journal-title":"Clin Liver Dis"},{"issue":"11","key":"5453_CR5","doi-asserted-by":"publisher","first-page":"820","DOI":"10.7326\/0003-4819-148-11-200806030-00004","volume":"148","author":"H Tanaka","year":"2008","unstructured":"Tanaka H, Imai Y, Hiramatsu N, Ito Y, Imanaka K, Oshita M, Hijioka T, Katayama K, Yabuuchi I, Yoshihara H. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med. 2008;148(11):820\u20136. https:\/\/doi.org\/10.7326\/0003-4819-148-11-200806030-00004 .","journal-title":"Ann Intern Med"},{"issue":"5","key":"5453_CR6","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2004.07.020","volume":"127","author":"JA Davila","year":"2004","unstructured":"Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology. 2004;127(5):1372\u201380. https:\/\/doi.org\/10.1053\/j.gastro.2004.07.020 .","journal-title":"Gastroenterology"},{"issue":"2","key":"5453_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390. https:\/\/doi.org\/10.3322\/caac.20107 .","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"5453_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1440-1746.2009.05784.x","volume":"24","author":"MF Yuen","year":"2009","unstructured":"Yuen MF, Hou JL, Chutaputti A. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol. 2009;24(3):346\u201353. https:\/\/doi.org\/10.1111\/j.1440-1746.2009.05784.x .","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"5453_CR9","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/MEG.0b013e32831a86f8","volume":"21","author":"F Farinati","year":"2009","unstructured":"Farinati F, Sergio A, Giacomin A, Di Nolfo MA, Del Poggio P, Benvegn\u00f9 L, Rapaccini G, Zoli M, Borzio F, Giannini EG. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? Eur J Gastroenterol Hepatol. 2009;21(10):1212\u20138. https:\/\/doi.org\/10.1097\/MEG.0b013e32831a86f8 .","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8-9","key":"5453_CR10","first-page":"505","volume":"91","author":"R Hefaiedh","year":"2013","unstructured":"Hefaiedh R, Ennaifer R, Romdhane H, Ben Nejma H, Arfa N, Belhadj N, Gharbi L, Khalfallah T. Gender difference in patients with hepatocellular carcinoma. Tunis Med. 2013;91(8-9):505\u20138.","journal-title":"Tunis Med"},{"issue":"24","key":"5453_CR11","doi-asserted-by":"publisher","first-page":"36814","DOI":"10.18632\/oncotarget.9192","volume":"7","author":"L Jiang","year":"2016","unstructured":"Jiang L, Shan J, Shen J, Wang Y, Yan P, Liu L, Zhao W, Xu Y, Zhu W, Su L, et al. Androgen\/androgen receptor axis maintains and promotes cancer cell stemness through direct activation of Nanog transcription in hepatocellular carcinoma. Oncotarget. 2016;7(24):36814\u201328. https:\/\/doi.org\/10.18632\/oncotarget.9192 .","journal-title":"Oncotarget"},{"issue":"5834","key":"5453_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1126\/science.1140485","volume":"317","author":"WE Naugler","year":"2007","unstructured":"Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317(5834):121\u20134. https:\/\/doi.org\/10.1126\/science.1140485 .","journal-title":"Science"},{"issue":"10","key":"5453_CR13","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/ijc.24720","volume":"125","author":"H Nakagawa","year":"2009","unstructured":"Nakagawa H, Maeda S, Yoshida H, Tateishi R, Masuzaki R, Ohki T, Hayakawa Y, Kinoshita H, Yamakado M, Kato N, et al. Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. Int J Cancer. 2009;125(10):2264\u20139. https:\/\/doi.org\/10.1002\/ijc.24720 .","journal-title":"Int J Cancer"},{"key":"5453_CR14","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/hep.25980","volume":"57","author":"J Hou","year":"2013","unstructured":"Hou J, Xu J, Jiang R, Wang Y, Chen C, Deng L, Huang X, Wang X, Sun B. Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3. Hepatology. 2013;57:678\u201388. https:\/\/doi.org\/10.1002\/hep.25980 .","journal-title":"Hepatology"},{"issue":"48","key":"5453_CR15","doi-asserted-by":"publisher","first-page":"40140","DOI":"10.1074\/jbc.M112.348763","volume":"287","author":"W Yang","year":"2012","unstructured":"Yang W, Lu Y, Xu Y, Xu L, Zheng W, Wu Y, Li L, Shen P. Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs). J Biol Chem. 2012;287(48):40140\u20139. https:\/\/doi.org\/10.1074\/jbc.M112.348763 .","journal-title":"J Biol Chem"},{"issue":"s2","key":"5453_CR16","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1111\/j.1872-034X.2007.00170.x","volume":"37","author":"DS Chen","year":"2007","unstructured":"Chen DS. Hepatocellular carcinoma in Taiwan. Hepatol Res. 2007;37(s2):S101\u20135.","journal-title":"Hepatol Res"},{"issue":"1-2","key":"5453_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000087267","volume":"49","author":"CM Lee","year":"2006","unstructured":"Lee CM, Hung CH, Lu SN, Wang JH, Tung HD, Huang WS, Chen CL, Chen WJ, Changchien CS. Viral etiology of hepatocellular carcinoma and HCV genotypes in Taiwan. Intervirology. 2006;49(1-2):76\u201381.","journal-title":"Intervirology"},{"issue":"15","key":"5453_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003284","volume":"95","author":"I-C Chang","year":"2016","unstructured":"Chang I-C, Huang S-F, Chen P-J, Chen C-L, Chen C-L, Wu C-C, Tsai C-C, Lee P-H, Chen M-F, Lee C-M, et al. The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network. Medicine. 2016;95(15):e3284. https:\/\/doi.org\/10.1097\/MD.0000000000003284 .","journal-title":"Medicine"},{"issue":"27","key":"5453_CR19","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1200\/JCO.2011.36.2335","volume":"29","author":"Y-T Huang","year":"2011","unstructured":"Huang Y-T, Jen C-L, Yang H-I, Lee M-H, Su J, Lu S-N, Iloeje UH, Chen C-J. Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol. 2011;29(27):3643\u201350. https:\/\/doi.org\/10.1200\/JCO.2011.36.2335 .","journal-title":"J Clin Oncol"},{"issue":"4","key":"5453_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/hep.20636","volume":"41","author":"JA Marrero","year":"2005","unstructured":"Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, Lok AS. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology. 2005;41(4):707\u201315. https:\/\/doi.org\/10.1002\/hep.20636 .","journal-title":"Hepatology"},{"issue":"3","key":"5453_CR21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/gut.2004.048124","volume":"54","author":"A Grieco","year":"2005","unstructured":"Grieco A, Pompili M, Caminiti G, Miele L, Covino M, Alfei B, Rapaccini GL, Gasbarrini G. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. Gut. 2005;54(3):411\u20138. https:\/\/doi.org\/10.1136\/gut.2004.048124 .","journal-title":"Gut"},{"issue":"4","key":"5453_CR22","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jhep.2005.12.015","volume":"44","author":"U Cillo","year":"2006","unstructured":"Cillo U, Vitale A, Grigoletto F, Farinati F, Brolese A, Zanus G, Neri D, Boccagni P, Srsen N, D'Amico F, et al. Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol. 2006;44(4):723\u201331. https:\/\/doi.org\/10.1016\/j.jhep.2005.12.015 .","journal-title":"J Hepatol"},{"issue":"3","key":"5453_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090929","volume":"9","author":"AI Gomaa","year":"2014","unstructured":"Gomaa AI, Hashim MS, Waked I. Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt. PLoS One. 2014;9(3):e90929. https:\/\/doi.org\/10.1371\/journal.pone.0090929 .","journal-title":"PLoS One"},{"issue":"6","key":"5453_CR24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1159\/000368008","volume":"32","author":"S Kitai","year":"2014","unstructured":"Kitai S, Kudo M, Izumi N, Kaneko S, Ku Y, Kokudo N, Sakamoto M, Takayama T, Nakashima O, Kadoya M, et al. Validation of three staging systems for hepatocellular carcinoma (JIS Score, Biomarker-Combined JIS Score and BCLC System) in 4,649 cases from a Japanese nationwide survey. Dig Dis. 2014;32(6):717\u201324. https:\/\/doi.org\/10.1159\/000368008 .","journal-title":"Dig Dis"},{"issue":"4","key":"5453_CR25","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","volume":"150","author":"J Bruix","year":"2016","unstructured":"Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150(4):835\u201353. https:\/\/doi.org\/10.1053\/j.gastro.2015.12.041 .","journal-title":"Gastroenterology"},{"issue":"1","key":"5453_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/hep.27443","volume":"61","author":"EG Giannini","year":"2015","unstructured":"Giannini EG, Farinati F, Ciccarese F, Pecorelli A, Rapaccini GL, Marco MD, Benvegn\u00f9 L, Caturelli E, Zoli M, Borzio F, et al. Prognosis of untreated hepatocellular carcinoma. Hepatology. 2015;61(1):184\u201390. https:\/\/doi.org\/10.1002\/hep.27443 .","journal-title":"Hepatology"},{"issue":"3","key":"5453_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1440-1746.2003.02936.x","volume":"18","author":"K Dohmen","year":"2003","unstructured":"Dohmen K, Shigematsu H, Irie K, Ishibashi H. Longer survival in female than male with hepatocellular carcinoma. J Gastroenterol Hepatol. 2003;18(3):267\u201372. https:\/\/doi.org\/10.1046\/j.1440-1746.2003.02936.x .","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"5453_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2016-000107","volume":"3","author":"MR Ladenheim","year":"2016","unstructured":"Ladenheim MR, Kim NG, Nguyen P, Le A, Stefanick ML, Garcia G, Nguyen MH. Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study. BMJ Open Gastroenterology. 2016;3(1):e000107. https:\/\/doi.org\/10.1136\/bmjgast-2016-000107 .","journal-title":"BMJ Open Gastroenterology"},{"key":"5453_CR29","first-page":"751","volume":"28","author":"G Capuano","year":"1998","unstructured":"Capuano G, Daniele B, Gaeta G, Gallo C, Perrone F. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology. 1998;28:751\u20135.","journal-title":"Hepatology"},{"issue":"1","key":"5453_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0168-8278(99)80173-1","volume":"31","author":"S Chevret","year":"1999","unstructured":"Chevret S, Trinchet J-C, Mathieu D, Rached AA, Beaugrand M, Chastang C. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. J Hepatol. 1999;31(1):133\u201341. https:\/\/doi.org\/10.1016\/S0168-8278(99)80173-1 .","journal-title":"J Hepatol"},{"issue":"6","key":"5453_CR31","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/cncr.10384","volume":"94","author":"TWT Leung","year":"2002","unstructured":"Leung TWT, Tang AMY, Zee B, Lau WY, Lai PBS, Leung KL, Lau JTF, Yu SCH, Johnson PJ. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system. Cancer. 2002;94(6):1760\u20139. https:\/\/doi.org\/10.1002\/cncr.10384 .","journal-title":"Cancer"},{"issue":"7","key":"5453_CR32","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1177\/000313481307900717","volume":"79","author":"NP Burnett","year":"2013","unstructured":"Burnett NP, Dunki-Jacobs EM, Callender GG, Anderson RJ, Scoggins CR, McMasters KM, Martin RC. Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients. Am Surg. 2013;79(7):716\u201322.","journal-title":"Am Surg"},{"issue":"3","key":"5453_CR33","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4254\/wjh.v7.i3.406","volume":"7","author":"A Kinoshita","year":"2015","unstructured":"Kinoshita A, Onoda H, Fushiya N, Koike K, Nishino H, Tajiri H. Staging systems for hepatocellular carcinoma: Current status and future perspectives. World J Hepatol. 2015;7(3):406\u201324. https:\/\/doi.org\/10.4254\/wjh.v7.i3.406 .","journal-title":"World J Hepatol"},{"issue":"4","key":"5453_CR34","first-page":"33","volume":"2","author":"S Subramaniam","year":"2013","unstructured":"Subramaniam S, Kelley RK, Venook AP. A review of hepatocellular carcinoma (HCC) staging systems. Chinese Clinical Oncology. 2013;2(4):33.","journal-title":"Chinese Clinical Oncology"},{"issue":"1","key":"5453_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/hep.25644","volume":"56","author":"WL Ma","year":"2012","unstructured":"Ma WL, Hsu CL, Yeh CC, Wu MH, Huang CK, Jeng LB, Hung YC, Lin TY, Yeh S, Chang C. Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis. Hepatology. 2012;56(1):176\u201385. https:\/\/doi.org\/10.1002\/hep.25644 .","journal-title":"Hepatology"},{"issue":"1\u20132","key":"5453_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cell.2011.11.026","volume":"148","author":"Z Li","year":"2012","unstructured":"Li Z, Tuteja G, Schug J, Kaestner Klaus H. Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer. Cell. 2012;148(1\u20132):72\u201383.","journal-title":"Cell"},{"issue":"6","key":"5453_CR37","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.hep.2003.09.041","volume":"38","author":"MW Yu","year":"2003","unstructured":"Yu MW, Chang HC, Chang SC, Liaw YF, Lin SM, Liu CJ, Lee SD, Lin CL, Chen PJ, Lin SC, et al. Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B\u2013 and C\u2013related risk. Hepatology. 2003;38(6):1393\u2013400. https:\/\/doi.org\/10.1016\/j.hep.2003.09.041 .","journal-title":"Hepatology"},{"issue":"9","key":"5453_CR38","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/ijc.29960","volume":"138","author":"KA McGlynn","year":"2016","unstructured":"McGlynn KA, Hagberg K, Chen J, Braunlin M, Graubard BI, Suneja N, Jick S, Sahasrabuddhe VV. Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink. Int J Cancer. 2016;138(9):2146\u201353. https:\/\/doi.org\/10.1002\/ijc.29960 .","journal-title":"Int J Cancer"},{"issue":"11","key":"5453_CR39","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.cgh.2017.05.036","volume":"15","author":"MM Hassan","year":"2017","unstructured":"Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, Phan AT, Hawk E, Javle M, Lee J-S, et al. Estrogen replacement reduces risk and increases survival times of women with hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2017;15(11):1791\u20139. https:\/\/doi.org\/10.1016\/j.cgh.2017.05.036 .","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5453_CR40","volume":"3","author":"A Nowak","year":"2004","unstructured":"Nowak A, Findlay M, Culjak G, Stockler M. Tamoxifen for hepatocellular carcinoma. Cochrane Database Syst Rev. 2004;3:CD001024.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"5453_CR41","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/hep.20474","volume":"40","author":"(GRETCH) GdEedTdCHe","year":"2004","unstructured":"(GRETCH) GdEedTdCHe. Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen. Hepatology. 2004;40(6):1361\u20139. https:\/\/doi.org\/10.1002\/hep.20474 .","journal-title":"Hepatology"},{"issue":"5","key":"5453_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/omi.2010.0108","volume":"15","author":"V Miceli","year":"2011","unstructured":"Miceli V, Cocciadiferro L, Fregapane M, Zarcone M, Montalto G, Polito LM, Agostara B, Granata OM, Carruba G. Expression of wild-type and variant estrogen receptor alpha in liver carcinogenesis and tumor progression. OMICS. 2011;15(5):313. https:\/\/doi.org\/10.1089\/omi.2010.0108 .","journal-title":"OMICS"},{"issue":"3","key":"5453_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1200\/JCO.2003.11.051","volume":"21","author":"E Villa","year":"2003","unstructured":"Villa E, Colantoni A, Camma C, Grottola A, Buttafoco P, Gelmini R, Ferretti I, Manenti F. Estrogen receptor classification for hepatocellular carcinoma: comparison with clinical staging systems. J Clin Oncol. 2003;21(3):441\u20136. https:\/\/doi.org\/10.1200\/JCO.2003.11.051 .","journal-title":"J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5453-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5453-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5453-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T22:09:41Z","timestamp":1606860581000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5453-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,20]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5453"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5453-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2019,3,20]]},"assertion":[{"value":"15 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board, Chang Gung Memorial Hospital, Taiwan [The ethical approval reference number: 201700107B0].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"250"}}